Bellvitge’s mHealth research stood out in the most relevant Congress of Heart Failure
The excellent results of the HERMeS clinical trial, a pioneer in the application of telemedicine and mHealth in Heart Failure, have been presented at the Heart Failure 2023 Congress, which took place between May 20 and 23 in Prague (Republic of Czech).
Bellvitge’s mHealth research stood out in the most relevant Congress of Heart Failure Read More »